Status:
COMPLETED
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Boston University
Conditions:
Drug Usage
Drug Abuse
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective of this study is to test whether screening and brief intervention for drug use among primary care patients leads to improved drug-related outcomes (such as decreased drug use and consequ...
Detailed Description
The efficacy of screening and brief intervention (SBI) for drug use among primary care patients is unknown. National organizations do not recommend universal screening. But policy is at odds with the ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Arrived for a visit in primary care
- ASSIST Substance Specific Involvement Score of greater than or equal to 4 for subjects included in primary analyses; ASSIST Substance-Specific Involvement Scores of 2 or 3 for subjects included only in exploratory analyses
- No previous MASBIRT intervention in the past 3 months
- Fluent in English or Spanish
- Two contacts who can assist with locating the subject for follow-up
- Able to return to Boston Medical Center in the next 6 months for research study visits
- Not pregnant (because care systems and resources differ greatly for such subjects)
- Able to be interviewed by trained research staff (excluding those in acute discomfort or with significantly impaired cognition)
Exclusion
- NOT 18 years of age or older
- NOT Arrived for a visit in primary care
- NO ASSIST Substance Specific Involvement Score of greater than or equal to 4 for subjects included in primary analyses; or NO ASSIST Substance-Specific Involvement Scores of 2 or 3 for subjects included only in exploratory analyses
- ANY previous MASBIRT intervention in the past 3 months
- NOT Fluent in English or Spanish
- FEWER THAN two contacts who can assist with locating the subject for follow-up
- NOT able to return to Boston Medical Center in the next 6 months for research study visits
- Pregnant (because care systems and resources differ greatly for such subjects)
- UN-Able to be interviewed by trained research staff (excluding those in acute discomfort or with significantly impaired cognition)
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
589 Patients enrolled
Trial Details
Trial ID
NCT00876941
Start Date
April 1 2009
End Date
September 1 2014
Last Update
October 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118